Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers

Abstract Background Ovarian cancers (OC) and cervical cancers (CC) have poor survival rates. Tumor-infiltrating lymphocytes (TILs) play a pivotal role in prognosis, but shared immune mechanisms remain elusive. Methods We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Hao, Zhang Yan, Luo Shen, Wang Hui, Qiu Ling, Yang Xiaoyu, Jiang Hua
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-025-01592-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585484821331968
author Feng Hao
Zhang Yan
Luo Shen
Wang Hui
Qiu Ling
Yang Xiaoyu
Jiang Hua
author_facet Feng Hao
Zhang Yan
Luo Shen
Wang Hui
Qiu Ling
Yang Xiaoyu
Jiang Hua
author_sort Feng Hao
collection DOAJ
description Abstract Background Ovarian cancers (OC) and cervical cancers (CC) have poor survival rates. Tumor-infiltrating lymphocytes (TILs) play a pivotal role in prognosis, but shared immune mechanisms remain elusive. Methods We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to explore immune regulation in OC and CC, focusing on the PI3K/AKT pathway and FLT3 as key modulators. Seurat and Harmony were employed for batch correction and dimensionality reduction. FLT3 expression was mapped with spatial data from 10 × Genomics. Results FLT3, identified as a regulator through the PI3K/AKT pathway, showed positive correlations with T cells, NK cells, and B cells. FLT3-high regions exhibited increased immune infiltration, particularly in CC, enhancing survival outcomes. Conclusion This study provides the first spatially resolved evidence of FLT3's immune-modulatory role in OC and CC, positioning it as a promising immunotherapeutic target. FLT3-targeted strategies may offer new options for patients resistant to conventional therapies.
format Article
id doaj-art-3b2079b5ffa94a53a46d9b8a79eb2952
institution Kabale University
issn 1757-2215
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj-art-3b2079b5ffa94a53a46d9b8a79eb29522025-01-26T12:47:44ZengBMCJournal of Ovarian Research1757-22152025-01-0118111910.1186/s13048-025-01592-8Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancersFeng Hao0Zhang Yan1Luo Shen2Wang Hui3Qiu Ling4Yang Xiaoyu5Jiang Hua6Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Cervical, Xiamen Women and Children’s Healthcare Hospital, Women’s and Children’s Hospital of Xiamen UniversityDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan UniversityHK International Regenerative CentreDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan UniversityAbstract Background Ovarian cancers (OC) and cervical cancers (CC) have poor survival rates. Tumor-infiltrating lymphocytes (TILs) play a pivotal role in prognosis, but shared immune mechanisms remain elusive. Methods We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to explore immune regulation in OC and CC, focusing on the PI3K/AKT pathway and FLT3 as key modulators. Seurat and Harmony were employed for batch correction and dimensionality reduction. FLT3 expression was mapped with spatial data from 10 × Genomics. Results FLT3, identified as a regulator through the PI3K/AKT pathway, showed positive correlations with T cells, NK cells, and B cells. FLT3-high regions exhibited increased immune infiltration, particularly in CC, enhancing survival outcomes. Conclusion This study provides the first spatially resolved evidence of FLT3's immune-modulatory role in OC and CC, positioning it as a promising immunotherapeutic target. FLT3-targeted strategies may offer new options for patients resistant to conventional therapies.https://doi.org/10.1186/s13048-025-01592-8FLT3PI3K/AKT pathwayTumor-infiltrating lymphocytes (TILs)Ovarian cancerCervical cancerSpatial transcriptomics
spellingShingle Feng Hao
Zhang Yan
Luo Shen
Wang Hui
Qiu Ling
Yang Xiaoyu
Jiang Hua
Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
Journal of Ovarian Research
FLT3
PI3K/AKT pathway
Tumor-infiltrating lymphocytes (TILs)
Ovarian cancer
Cervical cancer
Spatial transcriptomics
title Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
title_full Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
title_fullStr Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
title_full_unstemmed Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
title_short Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
title_sort reverse engineering the flt3 pi3k akt axis to enhance tils function and improve prognosis in ovarian and cervical cancers
topic FLT3
PI3K/AKT pathway
Tumor-infiltrating lymphocytes (TILs)
Ovarian cancer
Cervical cancer
Spatial transcriptomics
url https://doi.org/10.1186/s13048-025-01592-8
work_keys_str_mv AT fenghao reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT zhangyan reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT luoshen reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT wanghui reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT qiuling reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT yangxiaoyu reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers
AT jianghua reverseengineeringtheflt3pi3kaktaxistoenhancetilsfunctionandimproveprognosisinovarianandcervicalcancers